Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 21-35

  Willenborg, David O ^a   Staykova, Maria A ^a   Cowden, William B ^b,c  

^a CANBERRA HOSPITAL   (Australia)

^b Biology and Environment   (Australia)

^c Praxis Pharmaceuticals   (Australia)

Author keywords

Amino acid; Autoimmune encephalomyelitis; Nitric oxide

Indexed keywords

3 NITROTYROSINE; 7 NITROINDAZOLE; AMINOGUANIDINE; CELL SURFACE RECEPTOR; CYTOKINE; DEXAMETHASONE; INTERCELLULAR ADHESION MOLECULE 1; N(G) METHYLARGININE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; RECOMBINANT INTERLEUKIN 13; ROLIPRAM; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; AUTOIMMUNITY; INFLAMMATION; LIPID PEROXIDATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICE; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS;

EID: 0033400628     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00212-X     Document Type: Review

References (90)

1. Albina J.A., Henry W.L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50:1991;403-407.
2. Bachmann R., Eugster H.P., Frei K., Fontana A., Lassmann H. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am. J. Pathol. 154:1999;1417-1422.
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1620-1624.
4. Bogdan C. The multiplex function of nitric oxide in (auto)immunity. J. Exp. Med. 187:1998;1361-1365.
5. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
6. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:1981;614-620.
7. Brosnan C.F., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
8. Calza L., Giardino L., Pozza M., Micera A., Aloe L. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3368-3373.
9. Cash E., Minty A., Ferrara P., Caput D., Fradelizi D., Rott O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153:1994;4258-4267.
10. Clancy R.M., Leszczynska-Piziak J., Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1992;1116-1121.
11. Cowden W.B., Cullen F.A., Staykova M.A., Willenborg D.O. Nitric oxide is a potential downregulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1998;1-8.
12. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
13. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P.S., Manning P.T., Misko T.P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
14. Cross A.H., Manning P.T., Stern M.K., Misko T.P. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80:1997;121-130.
15. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2 mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
16. Deakin A.M., Payne A.N., Whittle B.J.R. The modulation of IL-6 and TNFα release by nitric oxide following stimulation of J774 cells with LPS and IFN gamma. Cytokine. 7:1995;408-416.
17. de Bustos F., Navarro J.A., deAndres C., Molina J.A., Jimenez-Jimenez F.J., Orti-Pareja M., Gasalla T., Tallon-Barranco A., Martinez-Salio A., Arenas J. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis. Eur. Neurol. 41:1999;44-47.
18. Ding M., Wong J.L., Rogers N.E., Ignarro L.J., Voskuhl R.R. Gender differences of inducible nitric oxide production in SJL/J mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 77:1997;99-106.
19. Ding M., Zhang M., Wong J.L., Rogers N.E., Ignarro L.J., Voskuhl R.R. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:1998;2560-2564.
20. Duhe R.J., Evans G.A., Erwin R.A., Kirken R.A., Cox G.W., Farrer W.L. Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl Acad. Sci. U.S.A. 95:1998;126-129.
21. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
22. Getting S.J., Flower R.J., Parente L., de Medicis R., Lussier A., Woliztky B.A., Martins M.A., Perretti M. Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. J. Pharmacol. Exp. Ther. 283:1997;123-130.
23. Giovannoni G., Heales S.J., Land J.M., Thompson E.J. The potential role of nitric oxide in multiple sclerosis. Mult. Scler. 4:1998;212-216.
24. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
25. Gordon T.P., Kowanko I.C., James M., Roberts Thomson P.J. Monosodium urate crystal-induced prostaglandin synthesis in the rat subcutaneous air pouch. Clin. Exp. Rheumatol. 3:1985;291-296.
26. Hewett S.J., Misko T.P., Keeling R.M., Behrens M.M., Choi D.W., Cross A.H. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J. Neuroimmunol. 64:1996;201-208.
27. Hogg, N., Kalyanaraman, B., Darley-Usmar, V., 1995. Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature. In: Davies, K.A.J., Ursini, F. (Eds.), The Oxygen Paradox. Cleup Press, Pandora, Italy, pp. 317-324.
28. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2528-2533.
29. Hooper D.C., Spitsin S., Kean R.B., Champion J.M., Dickson G.M., Chaudhry I., Koprowski H. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 95:1998;675-680.
30. Ialenti A.A., Ianaro I., Moncada S., DiRosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;171-182.
31. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84:1987;9265-9269.
32. Ishikawa M., Jin Y., Guo H., Link H., Xiao B.G. Nasal administration of transforming growth factor-beta1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis. Mult. Scler. 5:1999;184-191.
33. Jung S., Zielasek J., Kollner G., Donhauser T., Toyka K., Hartung H.P. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 68:1996;1-11.
34. Kamijo R., Shapiro D., Le J., Huang S., Auget M., Vilcek J. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon γ receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6626-6630.
35. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids. 27:1992;46-49.
36. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
37. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3024-3027.
38. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4651-4654.
39. Laszlo J., Evans S.M., Whittle B.J.R. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur. J. Pharmacol. 272:1995;169-175.
40. Lin R.F., Lin T.S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
41. Ludowyk P.A., Hughes W., Hugh A., Willenborg D.O., Rockett K.A., Parish C.R. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48:1993;121-134.
42. Machleidt T., Kramer B., Adam D., Neumann B., Schutze S., Wiegmann K., Kronke M. Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. J. Exp. Med. 184:1996;725-733.
43. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., Cowden W.B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
44. Margalit A., Hauser S.D., Zweifel B.S., Anderson M.A., Isakson P.C. Regulation of prostaglandin biosynthesis in vivo by glutathione. Am. J. Physiol. 274:1998;R294-302.
45. Martinez I., Puerta C., Redondo C., Garcia-Merino A. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase. J. Neurol. Sci. 164:1999;13-23.
46. McMillan R.M., Hasselbacher P., Hahn J.L., Harris E.D. Jr. Interactions of murine macrophages with monosodium urate crystals: stimulation of lysosomal enzyme release and prostaglandin synthesis. J. Rheumatol. 8:1981;555-562.
47. Misko T., Moore W.M., Kasten T.P. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
48. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:1995;195-204.
49. Moilanen, E., Whittle, B., Moncada, S., 1999. Nitric oxide as a factor in inflammation. In: Gallin, J.I., Snyderman, R., (Eds.), Inflammation: Basic Principles and Clinical Correlates. 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp. 787-800.
50. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
51. Monick M.M., Carter A.B., Gudmundsson G., Mallampalli R., Powers L.S., Hunninghake G.W. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J. Immunol. 162:1999;3005-3012.
52. Mulligan M.S., Heirel J.M., Marletta M.A., Ward P.A. Tissue injury caused by immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6338-6342.
53. Nathan C., Hibbs J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
54. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
55. O'Brien, N.C., Charlton, B., Cowden, W.B., Willenborg, D.O., 1999. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis (EAE) and in the maintenance of resistance to reinduction. J. Immunol., in press.
56. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
57. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;107-116.
58. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J. Neuroimmunol. 81:1998;201-210.
59. Parkinson J.F., Mitrovic B., Merrill J.E. The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75:1997;174-186.
60. Pilz R.B., Suhasini M., Idriss S., Meinkoth J.L., Boss G.R. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9:1995;552-558.
61. Polman C., Matthaei I., de Groot C.J.A., Koetsier J.C., Saminia T., Dijkstra C.D. Low-dose cyclosporine A induces relapsing remitting allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 17:1988;209-216.
62. Rajan A.J., Klein J.D., Brosnan C.F. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. J. Immunol. 160:1998;5955-5962.
63. Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
64. Sahrbacher U.C., Lechner F., Eugster H.P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1332-1338.
65. 2+)-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
66. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7240-7244.
67. Scott G.S., Williams K.I., Bolton C. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis. Inflammation Res. 45:1996;524-529.
68. Sherman M.P., Griscavage J.M., Ignarro L.J. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med. Hypotheses. 39:1992;143-146.
69. Sicher S.C., Vazquez M.A., Lu C.Y. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1304.
70. Smith T., Hewson A.K., Kingsley C.I., Leonard J.P., Cuzner M.L. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol. 150:1997;1909-1917.
71. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
72. Sun D., Coleclough C., Cao L., Hu X., Sun S., Whitaker J.N. Reciprocal stimulation between TNF-alpha and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 89:1998;122-130.
73. Tada Y., Ho A., Matsuyama T., Mak T.W. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 185:1997;231-238.
74. Taylor-Robinson A.W., Liew F.W., Steven A., Xu D., McSorley S.J., Garside P., Pardon J., Stephen Phillips R. Regulation of the immune response by nitric oxide differentially produced by T helper type-1 and T helper type 2 cells. Eur. J. Immunol. 24:1994;980-984.
75. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
76. Tran E.H., Hoekstra K., van Rooijen N., Dijkstra C.D., Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161:1998;3767-3775.
77. Tschaikowsky K., Schmidt J., Meisner M. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. J. Pharmacol. Exp. Ther. 285:1998;800-804.
78. Van Dam A.M., Bauer J., Man A., Hing W.K., Marquette C., Tilders F.J., Berkenbosch F. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40:1995;251-260.
79. van der Veen R.C., Roberts L.J. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol. 95:1999;1-7.
80. van der Veen R.C., Hinton D.R., Incardonna F., Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1997;1-7.
81. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughty D.A. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA. 91:1994;2046-2050.
82. Waldburger K.E., Hastings R.C., Schaub R.G., Goldman S.J., Leonard J.P. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am. J. Pathol. 148:1996;375-382.
83. Willenborg D.O. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123:1979;1145-1150.
84. Willenborg D.O., Fordham S.A., Bernard C.C.A., Cowden W.B., Ramshaw I.A. IFNγ plays a critical downregulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
85. Willenborg, D.O., Fordham, S.A., Staykova, A.A., Ramshaw, I.A., Cowden, W.B., 1999. Interferon gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. in press.
86. + T cells. J. Neuroimmunol. 97:1999;25-36.
87. Zettl U.K., Mix E., Zielasek J., Stangel M., Hartung H.P., Gold R. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell. Immunol. 178:1997;1-8.
88. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
89. Zielasek J., Tausch M., Toyka K.V., Hartung H.P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.
90. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.